Provided by Tiger Fintech (Singapore) Pte. Ltd.

Femasys Inc

1.47
-0.0350-2.33%
Volume:37.26K
Turnover:55.53K
Market Cap:33.55M
PE:-1.77
High:1.52
Open:1.50
Low:1.45
Close:1.50
Loading ...

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Feb

Femasys’s FemBloc: A Promising Investment in Permanent Contraceptive Innovation

TIPRANKS
·
26 Feb

Femasys announces publication of ‘positive’ results from FemBloc trials

TIPRANKS
·
25 Feb

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results From Fembloc® Permanent Birth Control Clinical Trials

THOMSON REUTERS
·
25 Feb

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

GlobeNewswire
·
25 Feb

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Feb

Femasys Announces UK Regulatory Approvals for Femaseed® for Female Infertility Treatment and Two Diagnostic Devices

THOMSON REUTERS
·
11 Feb

Femasys announces Israeli regulatory approvals for FemaSeed treatment

TIPRANKS
·
04 Feb

Femasys -Israeli Regulatory Approvals for Femaseed for Female Infertility Treatment and Two Diagnostic Devices

THOMSON REUTERS
·
04 Feb

Femasys announces notices of intention to grant 2 European patent applications

TIPRANKS
·
30 Jan

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of Fembloc Permanent Birth Control

THOMSON REUTERS
·
30 Jan

Femasys Gets Notice of Allowance for New US FemaSeed Patent

MT Newswires Live
·
17 Jan

BRIEF-Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

Reuters
·
16 Jan

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of Femaseed® for Female Infertility Treatment

THOMSON REUTERS
·
16 Jan

Femasys Inc: Expects Resulting Patent, When Issued, Will Have an Anticipated Expiration in 2044 at Earliest

THOMSON REUTERS
·
16 Jan

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Dec 2024